On November 06, 2019, S&E held an EU Life Science IP Study Session titled, “Patenting in the Field of Biotechnology, Biology and Pharmacy at the EPO – Problems and Possibilities”.

On November 06, 2019, S&E held an EU life science IP study session titled, “Patenting in the Field of Biotechnology, Biology and Pharmacy at the EPO – Problems and Possibilities”.

S&E invited Dr. Nino Maria Bratovic, Dr. rer. nat., Dipl.-Phys, European and German patent attorney, partner of the isarpatent Patent- und Rechtsanwälte and Dr. Tobias Rossteuscher, German and European patent attorney, Dr. rer. nat., Dipl.-Chem. of the isarpatent Patent- und Rechtsanwälte, which is located in Munich, Germany.

At the study session, Mr. Rosssteuscher provided an explanation of the legal basis, general principles, exclusions, and exceptions of patentability, biotechnology cases, and biology (such as animals and plants), microbiology, and pharmaceuticals-medical uses. Furthermore, he gave us some practical advice, such as how to protect data.

This Study session was held in English and Mr. Felix Einsel, our firm’s managing partner, provided an interpretation in Japanese.

S&E also had a reception after the study group to allow participants further opportunities to communicate with Dr. Nino Maria Bratovic and Dr. Tobias Rossteuscher.